These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6503978)

  • 61. [Peri-focal administration of OK-432 combined with radiotherapy in the treatment of esophageal cancer].
    Mukai M; Hiura T; Yamazaki Y; Nakajima K; Mikoshiba Y; Kasuya S; Nagao K
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1700-5. PubMed ID: 6870311
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
    Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
    Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1436-8. PubMed ID: 2586435
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 65. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Experimental studies on specific active immunotherapy using immune responses of irradiated tumor tissue. 4. Effects of a combined use of a non-specific immunopotentiator, OK-432].
    Imanaka K; Ogawa Y; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1299-304. PubMed ID: 7153621
    [No Abstract]   [Full Text] [Related]  

  • 67. [Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].
    Masuyama K; Tazawa K; Kasagi T; Yamashita I; Ishizawa S; Fujimaki M; Ochiai H; Niwayama S; Matsui H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1300-6. PubMed ID: 3230345
    [No Abstract]   [Full Text] [Related]  

  • 68. [Experimental studies on specific active immunotherapy using immune response of irradiated tumor tissues. 5. A combined effect of the immune response of cryopreserved tissue and OK-432].
    Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1305-10. PubMed ID: 7153622
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of intratumoral administration of OK-432 on breast cancer--analysis of T cell subsets of tumor infiltrating lymphocytes by using the immunohistological stainings--preliminary report].
    Hosokawa T; Haga S; Shimizu T; Iida T; Imamura H; Watanabe O; Kajiwara T
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):316. PubMed ID: 2787471
    [No Abstract]   [Full Text] [Related]  

  • 70. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2179-87. PubMed ID: 6530585
    [No Abstract]   [Full Text] [Related]  

  • 71. Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer.
    Tanaka N; Gouchi A; Ohara T; Mannami T; Konaga E; Fuchimoto S; Okamura S; Sato K; Orita K
    Cancer; 1994 Dec; 74(12):3097-103. PubMed ID: 7982173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential advantages in therapeutic index of OK-432 ointment to abdominal skin over systemic applied in a mouse model.
    Matsuoka H; Yano K; Wasasugi H; Seo Y; Saito T; Tomoda H
    Cancer Lett; 1996 Mar; 101(1):15-20. PubMed ID: 8625276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y; Inamoto T; Hori T; Kan N; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):597-608. PubMed ID: 4056544
    [No Abstract]   [Full Text] [Related]  

  • 74. Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus.
    Harada Y; Kurokawa E; Endo H; Kimura T; Saito M; Sugawara Y; Irie H; Ito K; Fujii M; Shimizu Y
    Microbiol Immunol; 1989; 33(6):467-77. PubMed ID: 2549347
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.
    Toge T; Yamada H; Aratani K; Kameda A; Kuroi K; Hisamatsu K; Hattori T
    Jpn J Surg; 1985 Jul; 15(4):260-5. PubMed ID: 2932585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):609-17. PubMed ID: 2932509
    [No Abstract]   [Full Text] [Related]  

  • 77. Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat.
    Saji S; Umemoto T; Kida H; Sakata K
    J Surg Oncol; 1985 Sep; 30(1):46-51. PubMed ID: 4079418
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432].
    Ogawa Y; Maeda T; Yoshida S; Yamamoto Y; Morita M; Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):946-50. PubMed ID: 6413627
    [No Abstract]   [Full Text] [Related]  

  • 79. Peri-operative immunotherapy with OK-432.
    Yokota M; Tagawa Y; Okada D; Yasutake T; Mine Y; Ishikawa H; Miyashita K; Tomita M; Tabuchi S
    Biotherapy; 1990; 2(3):207-12. PubMed ID: 2206773
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.
    Fukui H; Reynolds CW; Lenz B; Schneider M; Talmadge JE
    Cancer Immunol Immunother; 1989; 29(1):1-6. PubMed ID: 2784999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.